Gfbiochemicals Limited
7 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded as renamed to Gfbiochemicals IP Assets B.V. (2018)
9
Ending by 2030
Nov 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Jan 7, 2027
- 1 fee due Apr 13, 2027The maintenance fee for Carboxy ester ketals, methods of manufacture, and uses thereof (US 9,156,809) comes due Apr 13, 2027. Unpaid by Oct 13, 2027, it lapses early.
- 1 fee due May 17, 2027The maintenance fee for Polyhydroxy ketal ester adducts, methods of manufacture and uses thereof (US 9,187,598) comes due May 17, 2027. Unpaid by Nov 17, 2027, it lapses early.
- 3 fees due Jun 8 to 29, 2027 · next Jun 8
- 1 fee due Oct 5, 2027The maintenance fee for Fragrant formulations, methods of manufacture thereof and articles comprising the same (US 9,301,910) comes due Oct 5, 2027. Unpaid by Apr 5, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,178,701 | Glycerol levulinate ketals and their use In force · From the USPTO record | In force | From the USPTO record | |
| US 8,492,433 | Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom In force · From the USPTO record | In force | From the USPTO record | |
| US 8,906,961 | Glycerol levulinate ketals and their use in the manufacture of polyurethanes, and polyurethanes formed therefrom In force · From the USPTO record | In force | From the USPTO record | |
| US 8,053,468 | Glycerol levulinate ketals and their use In force · From the USPTO record | In force | From the USPTO record | |
| US 8,604,223 | Method of making ketals and acetals In force · From the USPTO record | In force | From the USPTO record | |
| US 8,653,223 | Transketalized compositions, synthesis, and applications In force · From the USPTO record | In force | From the USPTO record | |
| US 9,206,275 | Ketal ester derivatives In force · From the USPTO record | In force | From the USPTO record | |
| US 8,575,367 | Ketal ester derivatives In force · From the USPTO record | In force | From the USPTO record | |
| US 9,023,774 | Ketal Compounds and Uses Thereof In force · Medium confidence | In force | Medium confidence | |
| US 9,301,910 | Fragrant formulations, methods of manufacture thereof and articles comprising the same In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 29: 7 patents in force now held by others · 14 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 no status recorded